About
About Boai NKY Medical Holdings Ltd
Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precision medicine. It also offers pharmaceutical; hazardous chemical; food additive; medical protective equipment; medical device; manufacturing of basic chemical raw materials; import and export of goods and technology; technical services; and technology development, consulting, exchange, transfer, and promotion. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to Boai NKY Medical Holdings Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Jiaozuo, China.
Visit company website
5 years, 5 months ago
Boai NKY Medical Holdings Ltd is currently in a long term uptrend where the price is trading 8.7% above its 200 day moving average.
From a valuation standpoint, the stock is 61.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Boai NKY Medical Holdings Ltd's total revenue sank by 8.4% to $241M since the same quarter in the previous year.
Its net income has increased by 40.2% to $26M since the same quarter in the previous year.
Finally, its free cash flow grew by 169.3% to $142M since the same quarter in the previous year.
Based on the above factors, Boai NKY Medical Holdings Ltd gets an overall score of 4/5.